|
|
|
Volumn 26, Issue 1 SUPPL. 5, 1999, Pages 21-23
|
|
Comparing irinotecan with best supportive care and infusional 5- fluorouracil: A critical evaluation of the results of two randomized phase III trials
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
IRINOTECAN;
OXALIPLATIN;
ARTICLE;
CANCER SURVIVAL;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
HUMAN;
MAJOR CLINICAL STUDY;
METHODOLOGY;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CAMPTOTHECIN;
CLINICAL TRIALS, PHASE III;
DNA TOPOISOMERASES, TYPE I;
FLUOROURACIL;
HUMANS;
PALLIATIVE CARE;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0033044235
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (14)
|
